Importantly, CAFs have been proved to directly reduce the activation of CD8+ T cells and natural killer (NK) cells by upregulating the expression of immune checkpoint signals (e.g., PD-1, PD-L1, PD-L2), which in turn hinders anti-tumor immunity (13, 14). The gene discussed is PDCD1; the disease is neoplasm.